Liquid Pediatric Market Size & Share, by Type (Oral Solution, Emulsion), End User (Hospitals, Clinics, Homecare) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5504
  • Published Date: Jan 05, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Liquid Pediatric Market size is anticipated to reach USD 20 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of liquid pediatric was over USD 10 billion. The burgeoning demand for child-friendly medications, particularly in liquid form, stands as a pivotal growth driver for the market. This surge is propelled by a fundamental need to enhance medication adherence and ease administration for children who may struggle with swallowing conventional pills or tablets. Pharmaceutical companies are increasingly recognizing the significance of developing formulations that are not only efficacious but also palatable and easily consumable for the pediatric demographic. According to a survey, approximately 50% of parents reported that their children refuse to take medication at some point. Liquid medications offer a practical solution to the challenges associated with administering drugs to children. The palatable nature of liquid formulations makes it more appealing to children, significantly improving medication adherence.

Liquid pediatric refers to medications or medical products specifically formulated for pediatric use and administered in liquid form. This is often done to make it easier for children to take the medication, as they may have difficulty swallowing pills or tablets. Liquid formulations are also advantageous for accurate dosing in children, as doses can be adjusted more precisely based on the child's weight.

Liquid Pediatric Market
Get more information on this report: Request Free Sample PDF

Liquid Pediatric Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

~ USD 10 Billion

Forecast Year Market Size (2036)

~ USD 20 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Liquid Pediatric Sector: Growth Drivers and Challenges


Growth Drivers

  • Increasing Prevalence of Pediatric Chronic Conditions: The escalating prevalence of chronic conditions in the pediatric population is a significant growth driver for the liquid pediatric market. Chronic diseases such as asthma, diabetes, and various neurological disorders are on the rise among children. Liquid medications offer a practical and efficient means of delivering consistent treatment to manage these conditions. The need for sustained therapies in chronic pediatric illnesses propels the demand for liquid formulations, fostering market growth. According to a report by the World Health Organization (WHO), the global prevalence of childhood asthma has increased by approximately 30% in the past 20 years, affecting an estimated 339 million children and adolescents as of 2020. This surge in chronic conditions emphasizes the demand for effective and child-friendly medication formulations, driving growth in the market.
  • Rising Awareness of Pediatric Health and Medication Adherence: Increasing awareness among healthcare professionals and parents regarding the importance of pediatric health and medication adherence acts as a catalyst for the liquid pediatric market. Healthcare providers are actively promoting the use of liquid formulations to improve adherence rates in children, resulting in better therapeutic outcomes. The growing awareness of the impact of medication adherence on pediatric health fuels the demand for liquid medications. Pediatrics reported that medication adherence rates in pediatric patients significantly improved when liquid formulations were used, leading to better disease management.
  • Expansion of Pediatric Clinical Research and Trials: The expansion of clinical research and trials focused on pediatric populations is a crucial growth driver for the liquid pediatric market. Pharmaceutical companies are increasingly investing in pediatric-centric research to develop and validate the safety and efficacy of liquid formulations. The expansion of clinical trials contributes to a robust pipeline of pediatric medications, propelling the growth of the liquid pediatric market. The market is poised for substantial growth driven by a confluence of factors, including the increasing prevalence of pediatric chronic conditions, regulatory encouragement for pediatric formulations, parental preferences for liquid medications, technological advancements in drug delivery, rising awareness of pediatric health, and the expansion of pediatric clinical research.


  • Stability and Shelf Life Concerns: Liquid formulations are often more susceptible to degradation and have shorter shelf lives compared to their solid counterparts. This poses a challenge for manufacturers to ensure the stability of active ingredients over time, especially considering the potential storage conditions in various settings. According to a report by the World Health Organization (WHO), maintaining the stability of liquid pharmaceuticals, especially in resource-limited settings with suboptimal storage conditions, remains a significant challenge. This underscores the importance of robust formulation strategies and packaging to mitigate stability concerns.
  • Standardization of Dosing Instruments
  • Limited Palatability Options

Liquid Pediatric Segmentation

Type (Oral Solution, Emulsion)

The emulsion segment in the liquid pediatric market is estimated to gain the largest revenue share of 60% in the year 2036. The regulatory environment, with an emphasis on supporting pediatric drug development, acts as a growth driver for the emulsions segment. Regulatory bodies recognize the unique challenges in pediatric formulations and encourage innovation to meet the specific needs of children. Emulsions, with their formulation flexibility, align with regulatory goals for enhancing pediatric medication options. As of 2021, regulatory agencies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have implemented measures to incentivize pediatric drug development. These initiatives acknowledge the importance of diverse formulations, such as emulsions, in providing safe and effective treatment options for pediatric patients. The growth of the emulsions segment in the liquid pediatric market is driven by factors such as increased preference for palatable formulations, enhanced bioavailability, and regulatory support for pediatric drug development.

End User (Hospitals, Clinics, Homecare)

The hospitals segment in the liquid pediatric market is expected to garner a significant share in the year 2036. Hospital formulary decisions play a pivotal role in shaping the medication landscape within healthcare institutions. The preferences of hospital formularies for liquid pediatric medications are driven by considerations such as ease of administration, patient compliance, and the ability to customize dosages for individual pediatric patients. A survey conducted by the American Society of Health-System Pharmacists (ASHP) found that over 70% of hospital pharmacies prefer liquid formulations for pediatric patients. This preference reflects the emphasis on formulations that align with pediatric dosing requirements and contribute to effective and safe medication administration in a hospital setting. The growth of the hospitals segment in the liquid pediatric market is further propelled by factors such as the rising rate of pediatric admissions, the establishment of specialized pediatric units, the prevalence of respiratory conditions, enhanced medication adherence in inpatient settings, and hospital formulary preferences for liquid pediatric medications.

Our in-depth analysis of the global liquid pediatric market includes the following segments:


  • Oral Solution
  • Emulsion

          End User

  • Hospitals
  • Clinics
  • Homecare

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Liquid Pediatric Industry - Regional Synopsis

APAC Market Forecast

The liquid pediatric market in the Asia Pacific region is projected to hold the largest revenue share of 39% by the end of 2036. The growing awareness among parents regarding the importance of pediatric healthcare and medication adherence is a significant driver for the market. Parents actively seek child-friendly formulations, such as liquid medications, for their ease of administration and improved palatability, contributing to better medication adherence in children. A survey conducted by the Asia Pacific Pediatric Association (APPA) reported that over 80% of parents in the region expressed a preference for liquid medications for their children. The survey emphasized the impact of parental awareness on medication choices, highlighting the importance of catering to parental preferences in the market.

North American Market Statistics

The liquid pediatric market in the North America region is projected to hold the second largest share during the forecast period. A significant driver for the growth of the market in North America is the increasing prevalence of pediatric chronic conditions. Chronic diseases, such as asthma and diabetes, are on the rise among children, necessitating sustained and precise medication regimens. Liquid formulations offer a practical and effective means of administering medications in pediatric patients. As of 2021, the Centers for Disease Control and Prevention (CDC) reported that approximately 1 in 13 children in the United States has asthma, translating to around 7.4 million children. This underscores the substantial burden of chronic conditions among the pediatric population in North America, driving the demand for liquid pediatric medications. Advancements in drug delivery systems specific to pediatric patients contribute significantly to the growth of the market. Innovations in taste-masking technologies, improved stability of liquid formulations, and user-friendly packaging enhance the overall patient experience. These technological enhancements address the challenges associated with pediatric medication administration, fostering market expansion.

Research Nester
Liquid Pediatric Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Liquid Pediatric Market

    • Johnson & Johnson
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis International AG
    • Sanofi S.A.
    • Merck & Co., Inc.
    • AstraZeneca plc
    • Boehringer Ingelheim International GmbH
    • Eli Lilly and Company
    • AbbVie Inc.


In The News

  • In March 2023, Pfizer made a major move by acquiring Seagen, a global leader in antibody-drug conjugates (ADCs), for USD 43 billion. This acquisition strengthens Pfizer's oncology portfolio and positions them as a leading force in cancer treatment.
  • In 2023, Pfizer invested in ResApp Health, a company developing AI-powered tools for diagnosing respiratory diseases like pneumonia and tuberculosis using smartphone recordings. This partnership aims to improve access to accurate and affordable diagnosis in low- and middle-income countries where these diseases are prevalent.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5504
  • Published Date: Jan 05, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of liquid pediatric is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Merck & Co., Inc., and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Liquid Pediatric Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying